Today,
$ATAI announced outstanding Phase 2b data for BPL-003 (5-MeO-DMT).
In parallel, core shareholders – including myself and pharma company
@ferring – demonstrated conviction by investing $50 million together with top-tier biotech funds.
I firmly believe psychedelics have the potential to heal millions and fundamentally transform mental health treatment. In doing so, they will make a deep, positive dent in the universe. Especially in the times ahead, we humans need psychedelics more than ever.
My hope is for @atai_life to lead this revolution – scientifically, commercially, and spiritually.
atai is the greatest entrepreneurial endeavour of my life, and I believe it will yield rich returns – both financial and emotional – for everyone involved.
Check out my latest blog post:
christianangermayer.substack…